MB Angioklinika Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 49,266 |
| - |
| 12,614 |
| 11,971 |
| - |
| 80.59 |
| 24.30 |
| 19,451 |
| 2,049 |
| 17,627 |
| 3,586 |
| 0.03 |
| 0.11 |
| - |
| - |
| 25.60 |
| 12,614 |
| 2024 |
|---|
| 92,700 |
| - |
| 14,838 |
| 14,092 |
| - |
| 91.91 |
| 15.20 |
| 21,398 |
| 2,612 |
| 13,300 |
| 10,311 |
| 0.08 |
| 0.12 |
| - |
| - |
| 16.01 |
| 14,838 |
| 2025 |
|---|
| 129,594 |
| - |
| 43,350 |
| 40,778 |
| - |
| 92.47 |
| 31.47 |
| 26,503 |
| 4,588 |
| 8,169 |
| 1,181 |
| -0.03 |
| 0.17 |
| - |
| - |
| 33.51 |
| 43,422 |
| 2025 |
|---|
| 129,594 |
| - |
| 43,350 |
| 40,778 |
| - |
| 92.47 |
| 31.47 |
| 26,503 |
| 4,588 |
| 8,169 |
| 1,181 |
| -0.03 |
| 0.17 |
| - |
| - |
| 33.51 |
| 43,422 |
Turnover (€)
2025
Turnover (€)
129,594 €40 % *
Sales per employee (€)
-Profit before tax (€)
43,350 €192 % *
Net Profit (€)
40,778 €189 % *
Profit per employee (€)
-Total profitability (%)
92.47 %0.61 % *
Net profitability (%)
31.47 %107.04 % *
Equity (€)
26,503 €24 % *
Amounts Payable And Liabilities (€)
4,588 €76 % *
Non-current Assets (€)
8,169 €-39 % *
CurrentAssets (€)
1,181 €-89 % *
Working capital requirement
-0.03 -137.50 % *
Debt-to-equity ratio
0.17 41.67 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
33.51 %109.31 % *
EBIT (€)
43,422 €193 % *
